Stock overview
Arcus Biosciences Inc.
Explore the company, reported ownership, price history, and available source evidence.
ARCUS BIOSCIENCES INC (RCUS) is a healthcare or biotechnology equity security tracked from 13F filings.
- Last close
- $15.76
- · RCUS
- Tracked holders
- 4 funds
- Latest available 13F per fund
RCUS · USD
Price
Close · Nov 18, 2026
- Range low
- $15.76
- Range high
- $23.75
- Observations
- 23
- Session date
- Nov 18, 2026
Oct 19, 2026–Nov 18, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Samlyn Capital largest tracked holder Q3 2026 · filed Nov 16, 2026 · SEC filing | −10% 26'Q3 | $36,031,429 | 0.61% |
| Baker Bros. Advisors position history Q3 2026 · filed Nov 16, 2026 · SEC filing | — | $21,821,597 | 0.1% |
| Tudor Investment Corp position history Q3 2026 · filed Nov 16, 2026 · SEC filing | Newly reported 26'Q3 | $3,389,438 | 0% |
| Renaissance Technologies position history Q3 2026 · filed Nov 12, 2026 · SEC filing | Newly reported 26'Q3 | $2,647,575 | 0% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market